Ganoderic acid N (Standard)

Isoxepac (Standard) is the analytical standard of Isoxepac. This product is intended for research and analytical applications. Isoxepac (HP 549) is a nonsteroidal anti-inflammatory agent (NSAID) with anti-inflammatory, analgesic and antipyretic activity. Isoxepac has been studied in rat, rabbit, dog, rhesus monkey, etc[1][2][3].

Product Specifications

CAS Number

[110241-19-5]

UNSPSC

12352211

Target

Others; Reference Standards

Related Pathways

Others

Field of Research

Others

Smiles

O=C1CC[C@]2([C@]([H])(C1(C)C)C[C@@H](C([C@@](C)([C@@]3(C4)C)C(C[C@@H]3C(O)(C)CC(CC(C)C(O)=O)=O)=O)=C2C4=O)O)C

Molecular Formula

C30H42O8

Molecular Weight

530.65

References & Citations

[1]Zhenhao Li, et al. Screening Immunoactive Compounds of Ganoderma lucidum Spores by Mass Spectrometry Molecular Networking Combined With in vivo Zebrafish Assays. Front Pharmacol. 2020 Mar 18;11:287.|[2]Baosong Chen, et al. Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and α-glucosidase. Fitoterapia. 2017 Jul;120:6-16.